Ayahuasca and DMT: What They Are, Effects, and Real Risks

Ayahuasca and DMT: What They Are, Effects, and Real Risks

Psychedelics Guide › Ayahuasca and DMT: What They Are, Effects, and Real Risks

Ayahuasca (also known as yagé or, among the Shuar, natem) is an Amazonian brew that characteristically combines a vine—Banisteriopsis caapi—with plants rich in dimethyltryptamine (DMT), such as chacruna (Psychotria viridis). This guide brings together Psiconáutica’s educational work on this cluster: what the DMT molecule and its ultra-short-acting relatives like 5-MeO-DMT actually are, which plants contain them, how they have been used ritually for centuries, what recent clinical research indicates, and what is essential to know to approach them responsibly. We provide context, not recipes: understanding the phenomenon matters far more than prescribing anything.

Pharmacologically, the key to ayahuasca is a biochemical synergy: DMT ingested orally is degraded in the digestive tract by the enzyme monoamine oxidase (MAO), meaning it only becomes orally active when paired with beta-carbolines—such as harmaline and harmine from the vine or from Peganum harmala—that inhibit that MAO. This very inhibition explains why ayahuasca interacts with numerous medications (SSRI, SNRI, and MAOI antidepressants, among others) and certain foods, carrying the risk of severe reactions such as serotonin syndrome. For this reason, gathering thorough information beforehand is essential: any adjustments to psychiatric medication belong strictly in the hands of your doctor and must be addressed well in advance, never in the middle of a ceremonial setting.

We write from a perspective of harm reduction and honest rigor: distinguishing what evidence suggests from tradition, personal testimony, or myth, neither exaggerating dangers nor promising miracles, and assuming that our readers are adults capable of making their own informed choices. There are medical and psychiatric contraindications worth knowing, and the setting—who facilitates, where, and how—carries just as much weight as the pharmacology. In Spain and much of Europe, DMT is a controlled substance, and the legal status of ayahuasca as a brew remains ambiguous; beyond that objective fact, what follows seeks to unpack the chemical, cultural, and clinical dimensions of the phenomenon.

Featured reading

Recent studies and evidence

What the latest clinical research (Nature, JAMA, NEJM, Lancet, PubMed) reveals, reported with rigor and without hype.

What ayahuasca is: brew, tradition, and ritual use

The starting point for this cluster: what ayahuasca is, how the vine-chacruna synergy works, and how it has been experienced in Indigenous ritual contexts, viewed through a lens that separates tradition from scientific data.

DMT and 5-MeO-DMT: the molecule and its pharmacology

Dimethyltryptamine in the spotlight: a tryptamine present across numerous plants and trace amounts in mammals. Here we examine its pharmacological profile, ultra-short variants, and why its investigation was stalled by prohibition.

Plants and analogs: sources of DMT and beta-carbolines

From Syrian rue to Amazonian trees and seeds: the species that provide DMT, 5-MeO-DMT, bufotenin, or the MAO inhibitors that make the brew orally active.

Science and therapy: what the evidence says (and what it doesn’t)

Recent clinical research into DMT and long-term ritual ayahuasca use, presented with caution: preliminary results, methodological limitations, and why jumping to conclusions is premature.

Chronicles and experiences through a critical lens

Firsthand accounts written from a skeptical standpoint: an unvarnished look inside the ceremony, serving as a counterweight to magical thinking and psychedelic tourism.

Tryptamine chemistry (technical archive)

Historical and technical archival material on tryptamine chemistry and the indole core. Included for documentary and contextual reference; it does not constitute manufacturing instructions.

Frequently asked questions

What is ayahuasca, and what does it contain?

It is an Amazonian brew that combines the vine Banisteriopsis caapi with DMT-rich plants such as chacruna. The vine supplies beta-carbolines (harmine, harmaline) that inhibit the MAO enzyme, allowing DMT—which would otherwise be rapidly broken down in the gut—to become active orally. This botanical and molecular synergy is what makes it unique, and what is most vital to understand before considering any involvement.

What is DMT, and why is it said that our bodies produce it?

DMT (N,N-dimethyltryptamine) is a psychedelic tryptamine found in numerous plant species. Trace amounts have also been detected in mammalian tissues, giving rise to the popular notion of “endogenous” DMT. However, its physiological function remains unproven, so this concept is best approached with curiosity alongside healthy skepticism: it is an active area of research, not an established scientific fact.

Is it dangerous to combine ayahuasca with antidepressants?

Yes, it can be extremely dangerous, and this is one of the most critical safety issues to understand. The beta-carbolines in ayahuasca act as MAO inhibitors; combining them with SSRIs, SNRIs, or pharmaceutical MAOIs can trigger serotonin syndrome, a potentially life-threatening condition. There are also significant cardiovascular and other drug interactions to consider. If you take medication, consult your doctor or psychiatrist well in advance: any adjustment is a clinical decision between you and your healthcare provider, not something to resolve at a ceremony.

How do DMT and 5-MeO-DMT differ?

Both are related tryptamines, but they are distinctly different substances. 5-MeO-DMT features a methoxy group on the indole ring, is significantly more potent by weight, and is often characterized by a less “visual” and far more immersive, ego-dissolving, or overwhelming experience. 5-MeO-DMT is primarily associated with certain toad secretions and Virola tree snuffs, whereas DMT is the classic active alkaloid in ayahuasca. Confusing the two is a common and risky mistake, as their dosing profiles are not comparable.

Can ayahuasca or DMT treat depression?

This is currently one of the most compelling questions in psychiatric research. Ongoing clinical trials have yielded preliminary evidence suggesting antidepressant effects, but these studies remain limited, with small sample sizes conducted under strictly controlled clinical conditions. Promising results are not the same as definitive proof, and attending a ceremony is not equivalent to participating in a clinical trial. It is worth following the science with interest while avoiding assumptions about therapeutic guarantees that do not yet exist.

Is ayahuasca legal in Spain?

DMT is a controlled substance under international and Spanish law, meaning its possession and distribution are subject to legal penalties. Ayahuasca as a whole brew occupies a more ambiguous legal gray zone, resulting in conflicting judicial rulings depending on the case. This is an important reality to keep in mind; this guide is purely educational and does not constitute legal counsel.